Thursday, October 12, 2006

Health Canada approves promising new drug to treat multiple sclerosis

This sounds like a rather promising new drug approval. Hopefully it can provide some benefit to MS patients, despite a rare but potentially deadly adverse reaction. The risk to benefit ratio always has to be considered, but I fully expect that many MS patients with limited treatment options will appreciate a new possibility.

From CBC News:
Canadians with multiple sclerosis will soon have access to a highly touted new drug for the treatment of the relapsing-remitting form of the progressive neurodegenerative disease, following approval of the medication by Health Canada.

The new drug, to be sold under the brand name Tysabri, is the first in a new therapeutic class of MS treatments called selective adhesion molecule inhibitors and the first pharmaceutical advance for treating MS in 10 years, manufacturers Biogen Idec Canada and Elan Corp. said Wednesday. ...more

No comments: